Contact A Counsellor

counsellor button


Research on Depression in the Workplace.

For more information please click here



To subscribe to SADAG's newsletter, click here

To view previous newsletters - click here


Mental Health Matters Journal for Psychiatrists & GP's

MHM Volume 7 Issue1 small

Click here for more info on articles & how to subscribe


cope with cancer book

Literacy is a luxury that many of us take for granted.  We depend on written communication for information, guidance, and access to heath care information That is why SADAG created SPEAKING BOOKS and revolutionized the way information is delivered to low literacy communities. It's exactly what it sounds like.a book that talks to the reader in his or her local  language, delivering critical information in an interactive, and educational way.

The customizable 16-page book, accompanied by local celebrity audio recordings, ensures that vital health and social messages can be seen, heard, read and understood..

We started with books on Teen Suicide prevention , HIV, AIDS and Depression, Understanding Mental Health and have developed over 30 titles, such as TB, Malaria, Polio, Vaccines for over 30 countries.

suicide speaking book

By David Douglas

NEW YORK (Reuters Health) Jun 26 - Reducing the duration of untreated psychosis helps in prevention of negative symptom psychopathologies in patients with first-episode schizophrenia, Scandinavian and US researchers report in the June issue of the Archives of General Psychiatry.

As lead investigator Dr. Ingrid Melle told Reuters Health, "It is possible to get people with first episode psychosis into treatment earlier -- through better public information and lower thresholds for access to treatment -- and that shorter duration of untreated psychosis may prevent the development of more severe negative symptoms."

Dr. Melle, of Ulleval University Hospital, Oslo and colleagues followed 231 patients after a first episode of schizophrenia, 118 of whom were from a region with specialized psychiatric services including an early detection scheme for psychosis.

Over 2 years of follow-up, all patients received similar treatments. However, patients from the region with the early detection program had a significantly lower median duration of untreated psychosis (5 weeks, versus 16 weeks in patients from the area without the early detection program), better clinical status, and milder negative symptoms at the start of treatment.

The difference in negative symptoms was maintained at 1 and 2 years. There was also a trend toward better functional and social outcome in the early detection group.

Such early treatment is clearly important, Dr. Melle points out, "since negative symptoms are more treatment resistant than positive symptoms, and thus are a major contributor to disability in people with psychotic disorders."

Arch Gen Psychiatry 2008;65:634-640.


Our Sponsors

Our Partners